V Wealth Advisors’s VanEck Biotech ETF BBH Stock Holding History

V Wealth Advisors’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-3,312	Closed	-$427K	–	209
2017 Q4	$427K	Sell	3,312 -50	-1%	-$6.38K	0.22%	114
2017 Q3	$448K	Hold	3,362	–	–	0.23%	104
2017 Q2	$422K	Sell	3,362 -35	-1%	-$4.22K	0.2%	107
2017 Q1	$405K	Hold	3,397	–	–	0.25%	109
2016 Q4	$372K	Buy	+3,397	New	+$369K	0.27%	108

Other funds holding BBH

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

SFS

Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

BRM

Boston Research & Management Manchester, Massachusetts $421M AUM 16.18% 1-Year Est. Return

V Wealth Advisors's BBH Position: Q1 2018 in Review

V Wealth Advisors sold out of VanEck Biotech ETF (BBH) in Q1 2018, closing a stake of 3,312 shares — an estimated $427K sold.

V Wealth Advisors first reported a position in BBH in Q4 2016 and held it in 5 quarters. The position peaked at $448K in Q3 2017. 82 funds tracked by Wall St. Rank hold BBH as of Q1 2018.

V Wealth Advisors reported no remaining VanEck Biotech ETF position as of Q1 2018 after selling out during the quarter.
V Wealth Advisors sold 3,312 VanEck Biotech ETF shares in Q1 2018, an estimated $427K.
V Wealth Advisors first reported a position in VanEck Biotech ETF in Q4 2016 and held it in 5 quarters.
V Wealth Advisors's VanEck Biotech ETF position peaked at $448K in Q3 2017.
82 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2018.

Based on V Wealth Advisors's 13F filing for Q1 2018, filed 11 Apr 2018.